Endocrine therapy plus trastuzumab and pertuzumab shows excellent survival outcomes in HR and HER2 positive early BC

Status of anti BCMA therapy in myeloma

The promise of CAR T cell therapy for multiple myeloma

Positive data for the use of radioligand therapy in first-line neuroendocrine cancers

Multiple myeloma In Rwanda: The need for further research

Addressing the rise of multiple myeloma in Rwanda

Updates from ASCO 2024 in gastrointestinal tumours

Glofit-GemOx shows clinically meaningful benefit in relapsed/refractory diffuse large B-cell lymphoma

TP53 mutations are linked to unfavourable prognosis in chronic lymphocytic leukaemia

Novel CAR-T cell therapy shows promise against calreticulin mutant neoplasms

ASCO 2024: Lung cancer highlights

EHA 2024: Multiple myeloma roundup